ATE365530T1 - Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung - Google Patents

Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung

Info

Publication number
ATE365530T1
ATE365530T1 AT04000012T AT04000012T ATE365530T1 AT E365530 T1 ATE365530 T1 AT E365530T1 AT 04000012 T AT04000012 T AT 04000012T AT 04000012 T AT04000012 T AT 04000012T AT E365530 T1 ATE365530 T1 AT E365530T1
Authority
AT
Austria
Prior art keywords
skin care
product containing
care product
external use
retinol
Prior art date
Application number
AT04000012T
Other languages
English (en)
Inventor
Takeshi Yanagida
Okihiko Sakamoto
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27584926&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365530(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP22773392A external-priority patent/JP3417419B2/ja
Priority claimed from JP22773692A external-priority patent/JPH0632718A/ja
Priority claimed from JP22772792A external-priority patent/JPH0632729A/ja
Priority claimed from JP4227725A external-priority patent/JP2794252B2/ja
Priority claimed from JP22772892A external-priority patent/JP3545429B2/ja
Priority claimed from JP22773192A external-priority patent/JPH0632713A/ja
Priority claimed from JP22772992A external-priority patent/JP3455553B2/ja
Priority claimed from JP22773592A external-priority patent/JP3192235B2/ja
Priority claimed from JP22773092A external-priority patent/JPH0632712A/ja
Priority claimed from JP22773492A external-priority patent/JP3280712B2/ja
Priority claimed from JP22773292A external-priority patent/JP3192234B2/ja
Priority claimed from JP22773792A external-priority patent/JPH0632719A/ja
Priority claimed from JP22773892A external-priority patent/JP3313148B2/ja
Priority claimed from JP22773992A external-priority patent/JP3582016B2/ja
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of ATE365530T1 publication Critical patent/ATE365530T1/de
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06—Lipsticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AT04000012T 1992-07-13 1993-07-13 Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung ATE365530T1 (de)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
JP22772792A JPH0632729A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP4227725A JP2794252B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22772892A JP3545429B2 (ja) 1992-07-13 1992-07-13 レチノール安定配合皮膚外用剤
JP22773192A JPH0632713A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22772992A JP3455553B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773392A JP3417419B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773292A JP3192234B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773692A JPH0632718A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773492A JP3280712B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773792A JPH0632719A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773892A JP3313148B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773992A JP3582016B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773092A JPH0632712A (ja) 1992-07-13 1992-07-13 皮膚外用剤
JP22773592A JP3192235B2 (ja) 1992-07-13 1992-07-13 皮膚外用剤

Publications (1)

Publication Number Publication Date
ATE365530T1 true ATE365530T1 (de) 2007-07-15

Family

ID=27584926

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04000012T ATE365530T1 (de) 1992-07-13 1993-07-13 Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung
AT93914997T ATE266999T1 (de) 1992-07-13 1993-07-13 Dermatologische zusammensetzung

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT93914997T ATE266999T1 (de) 1992-07-13 1993-07-13 Dermatologische zusammensetzung

Country Status (6)

Country Link
US (2) US5484816A (de)
EP (3) EP1433477B1 (de)
KR (1) KR100295030B1 (de)
AT (2) ATE365530T1 (de)
ES (2) ES2289370T3 (de)
WO (1) WO1994001074A1 (de)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962000A (en) * 1992-07-13 1999-10-05 Shiseido Company, Ltd. External skin treatment composition
AU7532794A (en) * 1993-07-26 1995-02-20 Unilever Plc Cosmetic composition containing alpha hydroxy acids
US5681380A (en) 1995-06-05 1997-10-28 Kimberly-Clark Worldwide, Inc. Ink for ink jet printers
US6017661A (en) 1994-11-09 2000-01-25 Kimberly-Clark Corporation Temporary marking using photoerasable colorants
US5733693A (en) 1993-08-05 1998-03-31 Kimberly-Clark Worldwide, Inc. Method for improving the readability of data processing forms
US6017471A (en) 1993-08-05 2000-01-25 Kimberly-Clark Worldwide, Inc. Colorants and colorant modifiers
US6211383B1 (en) 1993-08-05 2001-04-03 Kimberly-Clark Worldwide, Inc. Nohr-McDonald elimination reaction
US5645964A (en) 1993-08-05 1997-07-08 Kimberly-Clark Corporation Digital information recording media and method of using same
US5685754A (en) 1994-06-30 1997-11-11 Kimberly-Clark Corporation Method of generating a reactive species and polymer coating applications therefor
US6071979A (en) 1994-06-30 2000-06-06 Kimberly-Clark Worldwide, Inc. Photoreactor composition method of generating a reactive species and applications therefor
US6242057B1 (en) 1994-06-30 2001-06-05 Kimberly-Clark Worldwide, Inc. Photoreactor composition and applications therefor
US6080393A (en) * 1994-07-09 2000-06-27 Johnson & Johnson Consumer Products, Inc. Skin care composition comprising a retinoid
US6461622B2 (en) 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US5976555A (en) * 1994-09-07 1999-11-02 Johnson & Johnson Consumer Products, Inc. Topical oil-in-water emulsions containing retinoids
US6008268A (en) 1994-10-21 1999-12-28 Kimberly-Clark Worldwide, Inc. Photoreactor composition, method of generating a reactive species, and applications therefor
BR9608367A (pt) 1995-06-05 1998-08-18 Kimberly Clark Co Pré-corantes novos
JP2000506550A (ja) 1995-06-28 2000-05-30 キンバリー クラーク ワールドワイド インコーポレイテッド 新規な着色剤および着色剤用改質剤
US6099628A (en) 1996-03-29 2000-08-08 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
ES2175168T3 (es) 1995-11-28 2002-11-16 Kimberly Clark Co Compuestos de colorantes estabilizados por la luz.
US5855655A (en) 1996-03-29 1999-01-05 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
US5782963A (en) 1996-03-29 1998-07-21 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
AR006049A1 (es) 1996-03-01 1999-07-21 Johnson & Johnson Consumer Una emulsion de aceite en agua
US5891229A (en) 1996-03-29 1999-04-06 Kimberly-Clark Worldwide, Inc. Colorant stabilizers
DE19632840A1 (de) * 1996-08-14 1998-02-19 Landsberger Albert Vitamin A-haltige Zusammensetzung
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
DE69719528T2 (de) * 1996-09-27 2003-11-06 Unilever Nv Hautpflegemittel enthaltend kombinationen aus verbindungen die die wirkungvon retinsaüre auf der haut nachbilden
DE19713092A1 (de) * 1997-03-27 1998-10-01 Wacker Chemie Gmbh Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
DE19718318A1 (de) * 1997-04-30 1998-11-05 Beiersdorf Ag Wirkstoffkombinationen bzw. Addukte aus Dibenzoylmethanderivaten und/oder Zimtsäurederivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Lichtschutzzubereitungen
FR2763853B1 (fr) * 1997-05-28 2000-01-07 Oreal Association d'un retinoide avec un polymere polyamine
US6524379B2 (en) 1997-08-15 2003-02-25 Kimberly-Clark Worldwide, Inc. Colorants, colorant stabilizers, ink compositions, and improved methods of making the same
IN187860B (de) * 1997-08-27 2002-07-06 Revlon Consumer Prod Corp
US5972355A (en) * 1997-09-30 1999-10-26 E-L Management Corp. Stable compositions containing biologically active components
WO1999056720A1 (en) * 1998-05-07 1999-11-11 The Procter & Gamble Company A composition containing an ascorbic acid compound
SK1552000A3 (en) 1998-06-03 2000-08-14 Kimberly Clark Co Novel photoinitiators and applications therefor
SK1542000A3 (en) 1998-06-03 2001-11-06 Kimberly Clark Co Neonanoplasts produced by microemulsion technology and inks for ink jet printing
JP2002520470A (ja) 1998-07-20 2002-07-09 キンバリー クラーク ワールドワイド インコーポレイテッド 改良されたインクジェットインク組成物
EP0988854B1 (de) 1998-09-21 2004-07-14 Shiseido Company Limited Zusammensetzung zur äusserlichen Anwendung enthaltend Succinoglucan, Tonerde und ein Alkylacrylat/methacrylat Copolymer
BR9914123B1 (pt) 1998-09-28 2010-11-30 fotoiniciadores e aplicações para os mesmos.
MY123201A (en) * 1998-11-06 2006-05-31 Kao Corp Plant-activating agent
EP1144512B1 (de) 1999-01-19 2003-04-23 Kimberly-Clark Worldwide, Inc. Farbstoffe, farbstoffstabilisatoren, tintenzusammensetzungen und verfahren zu deren herstellung
US6331056B1 (en) 1999-02-25 2001-12-18 Kimberly-Clark Worldwide, Inc. Printing apparatus and applications therefor
US6294698B1 (en) 1999-04-16 2001-09-25 Kimberly-Clark Worldwide, Inc. Photoinitiators and applications therefor
US6368395B1 (en) 1999-05-24 2002-04-09 Kimberly-Clark Worldwide, Inc. Subphthalocyanine colorants, ink compositions, and method of making the same
DE19943678A1 (de) * 1999-09-13 2001-03-15 Beiersdorf Ag Wirkstoffkombinationen aus oberflächenaktiven Citronensäureestern und Einschlußverbindungen von Cyclodextrinen und Retinoiden sowie kosmetische und dermatologische Zubereitungen mit einem Gehalt an solchen Gemischen
JP3503884B2 (ja) * 2000-01-28 2004-03-08 花王株式会社 化粧料
DE10003786A1 (de) * 2000-01-28 2001-08-02 Merck Patent Gmbh Galenische Formulierung
US6531141B1 (en) 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
KR100404868B1 (ko) * 2000-03-28 2003-11-15 김삼 안정한 레티놀 팔미테이트 및 그를 함유하는 화장료 조성물
US6468552B1 (en) * 2000-06-02 2002-10-22 Neutrogena Corporation Stabilized compositions containing oxygen-labile active agents
US6353029B1 (en) * 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
JP2002284705A (ja) * 2001-01-19 2002-10-03 Shiseido Co Ltd 刺激緩和剤
CA2456743A1 (en) * 2001-08-21 2003-02-27 Galileo Pharmaceuticals, Inc. Tocopherol enriched compositions and amelioration of inflammatory symptoms
US20030059446A1 (en) * 2001-09-18 2003-03-27 Kulkarni Arun B. Physically stable sprayable gel composition
US6830746B2 (en) 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions
DE10151245A1 (de) * 2001-10-17 2003-05-15 Beiersdorf Ag Kosmetische und/oder dermatologische Wirkstoffkombination
AU2002352726A1 (en) * 2001-11-15 2003-06-10 Galileo Laboratories, Inc. Formulations and methods for treatment or amelioration of inflammatory conditions
EP1474109B1 (de) 2001-12-21 2010-08-25 Alcon, Inc. Verwendung von synthetischen anorganischen nanoteilchen als träger für augenmedikamente
EP1471925A2 (de) * 2001-12-21 2004-11-03 Alcon, Inc. Anorganische nanopartikel zur modifizierung der viskosität und physikalischer eigenschaften von ophthalmischen und ohrenheilkundigen zusammensetzungen
FR2835434B1 (fr) * 2002-02-01 2006-03-03 Lvmh Rech Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee
US20030165546A1 (en) * 2002-03-04 2003-09-04 The Procter & Gamble Company Stable personal care compositions containing a retinoid
DE10218181A1 (de) * 2002-04-24 2003-11-06 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen auf der Grundlage von W/O-Emulsionen mit einem Gehalt an Traubenkernöl und einem oder mehreren Siliconemulgatoren
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
DE10233740A1 (de) * 2002-07-24 2004-02-05 Basf Ag Retinoid-haltige Zubereitungen
FR2843125B1 (fr) * 2002-08-02 2012-11-16 Coletica Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs
CN101703047A (zh) * 2002-08-12 2010-05-12 隆萨股份有限公司 抗菌组合物
US20050042233A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent and a fungal extract
US20050042306A1 (en) * 2003-08-21 2005-02-24 Christopher Marrs Stabilized compositions containing an oxygen-labile active agent
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CA2545788A1 (en) * 2003-11-13 2005-06-02 Galileo Pharmaceuticals, Inc. Plant-derived protein extract compositions and methods
CA2559607C (en) * 2004-03-15 2013-02-19 3M Innovative Properties Company Immune response modifier formulations and methods
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
WO2006099325A2 (en) 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
FR2894827B1 (fr) * 2005-12-21 2010-10-29 Galderma Res & Dev Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations
JP4222370B2 (ja) * 2006-01-11 2009-02-12 セイコーエプソン株式会社 デバッグ支援装置及びデバッグ処理方法をコンピュータに実行させるためのプログラム
US20100298259A1 (en) * 2007-05-11 2010-11-25 Marc Moutet Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same
CA2686511A1 (fr) * 2007-05-11 2008-11-20 Galderma Research & Development Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
EP2148727A2 (de) * 2007-05-11 2010-02-03 Galderma Research & Development Pharmazeutische oder kosmetische präparate zur topischen und/oder parenteralen anwendung, verfahren zu ihrer herstellung und ihre anwendung
EP2155212A2 (de) * 2007-05-11 2010-02-24 Galderma Research & Development Pharmazeutische oder kosmetische präparate zur topischen und/oder parenteralen anwendung, verfahren zu ihrer herstellung und ihre anwendung
WO2008150947A2 (en) * 2007-05-30 2008-12-11 Dow Corning Corporation Silicone copolymers and elastomers derived from natural oils
CN102256666B (zh) 2008-12-22 2015-05-20 法国强生及强生消费者控股公司 治疗皮肤病症的组合物和方法
CN102652165B (zh) 2009-11-24 2014-04-02 株式会社资生堂 包合紫外线吸收剂的粘土矿物及含该粘土矿物的化妆品
US8410079B2 (en) 2010-08-06 2013-04-02 Island Kinetics Chirally correct retinal cyclodextrin hemiacetals for clarifying skin complexion
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
KR20130138551A (ko) * 2012-06-11 2013-12-19 한국콜마주식회사 점도 안정화 특성을 갖는 조성물
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US10226550B2 (en) * 2016-03-11 2019-03-12 Brigham Young University Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
CN111918641A (zh) * 2017-12-29 2020-11-10 马特克斯拉比有限公司 包括中和步骤的制备具有透明质酸基的填充剂的方法
CN111918642A (zh) * 2017-12-29 2020-11-10 马特克斯拉比有限公司 包括中和步骤的制备具有透明质酸基的填充剂的方法
KR102849062B1 (ko) 2018-12-04 2025-08-21 닛신 오일리오그룹 가부시키가이샤 유성 보습제 및 그것을 포함하는 피부 외용 조성물
CN112294693B (zh) * 2019-07-26 2021-07-20 珀莱雅化妆品股份有限公司 一种视黄醇及其衍生物的超分子制剂及其制备方法
JP2021161030A (ja) * 2020-03-30 2021-10-11 サンスター株式会社 化粧用組成物及びレチノイドの安定化方法
CN117430962B (zh) * 2023-10-26 2024-06-21 郑州市欧普士科技有限公司 一种opgw光缆用填充膏及其制备方法
CN120154737A (zh) * 2023-12-15 2025-06-17 湖南派格兰药业有限公司 一种脂溶性维生素制剂中间体及其制备方法

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33845A (en) * 1861-12-03 Improvement in harvesting-machines
GB1126289A (en) * 1966-05-12 1968-09-05 Hoffmann La Roche Water-dispersible water-free vitamin preparations and a process for the manufacture thereof
US3622668A (en) * 1969-08-27 1971-11-23 Joe B Moss Method of promoting scar-free healing of skin lacerations
US3729568A (en) * 1969-09-23 1973-04-24 Johnson & Johnson Acne treatment
ZA713539B (en) * 1970-06-23 1972-02-23 Hoffmann La Roche Pharmaceutical compositions
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US4011323A (en) * 1974-03-18 1977-03-08 Sandoz, Inc. Bi-4-[1-(quinazolinyl-4)piperidyls] and bis{4-[1-(quinazolinyl-4)piperidyl]alkanes}
US4011313A (en) * 1974-06-07 1977-03-08 Syntex (U.S.A.) Inc. Medicament preparations
US4154823A (en) * 1976-06-10 1979-05-15 Schutt Steven R Skin treatment compositions and methods of using same
US4333924A (en) * 1978-08-09 1982-06-08 Beecham Group Limited Retinol acetate skin-care compositions
US4248861A (en) * 1979-02-21 1981-02-03 Schutt Steven R Skin treatment methods
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4371673A (en) * 1980-07-21 1983-02-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble forms of retinoids
JPH0244806B2 (ja) * 1981-09-07 1990-10-05 Sunstar Kk Bitaminaoanteinihaigoshitanyukakeihifugaiyozaisoseibutsu
US4454159A (en) * 1981-12-28 1984-06-12 Albert Musher Dermatological treatment preparations
EP0094771B1 (de) * 1982-05-15 1987-08-05 Beecham Group Plc Hautbehandlungsmittel
US4505902A (en) * 1982-09-15 1985-03-19 Millard Mary A Skin treatment preparation
US4604281A (en) * 1983-03-21 1986-08-05 Charles Of The Ritz Group Ltd. Cosmetic and skin treatment compositions containing acetylated sterols
GB2141626B (en) * 1983-04-25 1987-01-28 Kao Corp Cinnamic acid derivatives for lightening melanin pigmentation of skin
US4481186A (en) * 1983-05-27 1984-11-06 Charles Of The Ritz Group Ltd. Non-irritating cosmetic composition containing glucamine fatty acid emulsifier soap
JPH0832621B2 (ja) * 1985-02-28 1996-03-29 株式会社資生堂 皮膚外用剤
JPS60181014A (ja) * 1984-02-27 1985-09-14 Ichiro Shibauchi 浴剤およびその製造方法
EP0343694B1 (de) * 1984-03-07 1992-11-25 Roshdy Dr. Ismail Mittel zur Behandlung und zum Schutz der Haut
US4695452A (en) * 1984-10-10 1987-09-22 Gannis Peter M Cosmetic stick
SU1329743A1 (ru) * 1984-12-19 1987-08-15 Украинский Научно-Исследовательский Институт Мясной И Молочной Промышленности Композици дл производства молочного продукта дл детского и диетического питани
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
AU5772686A (en) * 1985-04-22 1986-11-18 Avon Products Inc. Composition and method for reducing wrinkles
JPS62419A (ja) * 1985-06-26 1987-01-06 Shiseido Co Ltd 脂溶性ビタミン含有水溶性剤
FR2584925B1 (fr) * 1985-07-17 1987-11-27 Bosserelle Micheline Composition de corps gras d'origine vegetale pour usage cosmetique
US4603046A (en) * 1985-08-23 1986-07-29 Charles Of The Ritz Group Ltd. Improved sunscreen or sunblock composition
US4742066A (en) * 1986-03-17 1988-05-03 Charles Of The Ritz Group Ltd. Skin treatment composition and method
US4970216A (en) * 1986-03-17 1990-11-13 Richardson Vicks, Inc. Skin treatment composition and method
US4847267A (en) * 1986-03-17 1989-07-11 Charles Of The Ritz Group Ltd. Skin treatment composition and method
ZA872460B (en) * 1986-04-07 1987-12-30 Bristol Myers Co Stable injectable antiemetic compositions
JPH0643390B2 (ja) * 1986-04-08 1994-06-08 久光製薬株式会社 アザシクロアルカン誘導体
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
NL8601767A (nl) * 1986-07-07 1988-02-01 Schreuder Chem Adviesbureau Huidbruiningsmiddel.
JPS6383021A (ja) * 1986-09-26 1988-04-13 Kao Corp 内服液剤組成物
US4863970A (en) * 1986-11-14 1989-09-05 Theratech, Inc. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
JPS63135309A (ja) * 1986-11-28 1988-06-07 Shiseido Co Ltd 皮膚外用剤
JPS63188609A (ja) * 1987-01-30 1988-08-04 Sansho Seiyaku Kk 着色を防止した外用剤
DE3851203T2 (de) * 1987-05-11 1994-12-15 Procyte Corp Gebrauch von GHL-Cu Derivaten für die Herstellung eines Medikaments zur Stimulierung des Haarwachstums.
JP2506384B2 (ja) * 1987-09-25 1996-06-12 三省製薬株式会社 外用剤
US4769234A (en) * 1987-10-06 1988-09-06 Peter M. Stephan Center Ltd. Skin care compositions containing polyvalent equine immune serum
LU87030A1 (fr) * 1987-10-28 1989-05-08 Oreal Utilisation en cosmetique de nouvelles substances a titre de reflecteurs du rayonnement infrarouge,compositions cosmetiques les contenant et leur utilisation pour la protection de l'epiderme humain contre le rayonnement infrarouge
JP2614474B2 (ja) * 1988-01-20 1997-05-28 サンスター株式会社 美白化粧料
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
JPH01246208A (ja) * 1988-03-28 1989-10-02 Shiseido Co Ltd 皮膚外用剤
AU616538B2 (en) * 1988-07-08 1991-10-31 Shiseido Company Ltd. Silicone type cinnamic acid derivative, preparation method thereof, uv-ray absorber, and external skin treatment agent
US4906457A (en) * 1988-09-06 1990-03-06 Washington State University Research Foundation, Inc. Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
JPH02142713A (ja) * 1988-11-25 1990-05-31 Shiseido Co Ltd 皮膚外用剤
EP0481007B1 (de) * 1989-06-07 1997-01-22 BAZZANO, Gail S VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
KR930001805B1 (ko) * 1989-10-02 1993-03-13 브리스톨-마이어즈 스퀴브 컴페니 안정성이 개선된 트리티노인 유화크림 제제
US5061480A (en) * 1989-11-03 1991-10-29 Marchese Co., Inc. Tanning composition
JP3014780B2 (ja) * 1990-01-29 2000-02-28 ジヨンソン・アンド・ジヨンソン・コンシユーマー・プロダクツ・インコーポレーテツド スキンケア組成物
US5102654A (en) * 1990-04-18 1992-04-07 Revlon, Inc. Nail enamel emulsion lacquer comprising a water phase and a lacquer phase
US5246611A (en) * 1990-05-09 1993-09-21 The Procter & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
FR2668930B1 (fr) * 1990-11-09 1995-02-17 Oreal Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion aqueuse de vesicules lipidiques.
JP2928892B2 (ja) * 1990-11-27 1999-08-03 三洋化成工業株式会社 外科用接着剤
DE4100490C1 (de) * 1991-01-10 1992-03-05 Goldwell Ag, 6100 Darmstadt, De
GB9109965D0 (en) * 1991-05-07 1991-07-03 Unilever Plc Cosmetic composition
JP3435510B2 (ja) * 1991-06-27 2003-08-11 ジヨンソン・アンド・ジヨンソン・コンシユーマー・プロダクツ・インコーポレーテツド スキンケア組成物
SE9102890D0 (sv) * 1991-10-07 1991-10-07 Hans Evers Insektsrepelleringsmedel
US5281196A (en) * 1992-05-22 1994-01-25 Sultenfuss Thomas J Skin treatment composition and method of use

Also Published As

Publication number Publication date
EP1433477A2 (de) 2004-06-30
ES2221921T3 (es) 2005-01-16
EP1433477A3 (de) 2004-10-20
ES2289370T3 (es) 2008-02-01
EP0608433B1 (de) 2004-05-19
US6024941A (en) 2000-02-15
EP0608433A4 (de) 1998-09-16
WO1994001074A1 (fr) 1994-01-20
EP1714640A1 (de) 2006-10-25
KR100295030B1 (ko) 2001-09-17
EP0608433A1 (de) 1994-08-03
US5484816A (en) 1996-01-16
EP1433477B1 (de) 2007-06-27
ATE266999T1 (de) 2004-06-15

Similar Documents

Publication Publication Date Title
ATE365530T1 (de) Retinolthaltiges, stabilisiertes hautpflegemittel zur äusserlichen anwendung
HUP9801607A2 (hu) Retinoidokat és liposzómákat tartalmazó bőrápoló készítmény
DK0578077T3 (da) Præparater, der indeholder retinsyrer og tocopherol
ATE123787T1 (de) Herstellung von peroxid enthaltenden perfluorpolyäthern.
FR2713635B1 (fr) Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE69435330D1 (de) Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen
DE59508891D1 (de) Hautpflegemittel
DE59105808D1 (de) Verwendung von pharmazeutischen und kosmetischen Präparaten mit Mischmicellen.
ATE12729T1 (de) Haarbehandlungsmittel.
ATE15442T1 (de) Haarbehandlungsmittel des typs vorshampoo.
EA200000045A1 (ru) Косметическая композиция, содержащая отбеливающее и отшелушивающее средства
MX172076B (es) Composicion de enriquecimiento para el cabello
KR930012022A (ko) 뇌조직 보호용 모다피닐(Modafinil)
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
AU1798995A (en) Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin
DE69629989D1 (de) Präparate zur äusserlichen anwendung zur behandlung von dermatosen
MY130044A (en) Retinoid composition
FI954111A7 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset v almisteet
NL194612B (nl) Aromatische, alkenisch onverzadigde retino´den, alsmede dergelijke verbindingen bevattende farmaceutische en cosmetische preparaten.
BR0207654A (pt) Composição que compreende um creme ou loção base
FR2713640B1 (fr) Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FI961938L (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
ATE227557T1 (de) Verwendung von zahnpflegemitteln enthaltend bovines kolostrum
ATE151774T1 (de) Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen
ES2091981T3 (es) Procedimiento para la fabricacion de preparaciones de crema estables, hidrofilas o ambifilas, que contienen componentes vesiculares, asi como el uso de las mismas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties